Genome-Wide Classification of Myb Domain-Containing Protein Families in Entamoeba invadens
Genes · 2024
DOI: 10.3390/genes15020201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Patricia Cuellar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City C.P. 03100, Mexico. Hauptthemen laut MEDLINE: Entamoeba, Entamoeba histolytica, Amebiasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Universidad Autónoma de la Ciudad de México, CONAHCYT.
Abstract (Originalsprache)
Entamoeba histolytica, the causative agent of amebiasis, is the third leading cause of death among parasitic diseases globally. Its life cycle includes encystation, which has been mostly studied in Entamoeba invadens, responsible for reptilian amebiasis. However, the molecular mechanisms underlying this process are not fully understood. Therefore, we focused on the identification and characterization of Myb proteins, which regulate the expression of encystation-related genes in various protozoan parasites. Through bioinformatic analysis, we identified 48 genes in E. invadens encoding MYB-domain-containing proteins. These were classified into single-repeat 1R (20), 2R-MYB proteins (27), and one 4R-MYB protein. The in-silico analysis suggests that these proteins are multifunctional, participating in transcriptional regulation, chromatin remodeling, telomere maintenance, and splicing. Transcriptomic data analysis revealed expression signatures of eimyb genes, suggesting a potential orchestration in the regulation of early and late encystation–excystation genes. Furthermore, we identified probable target genes associated with reproduction, the meiotic cell cycle, ubiquitin-dependent protein catabolism, and endosomal transport. In conclusion, our findings suggest that E. invadens Myb proteins regulate stage-specific proteins and a wide array of cellular processes. This study provides a foundation for further exploration of the molecular mechanisms governing encystation and unveils potential targets for therapeutic intervention in amebiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City C.P. 03100, Mexico.
- Licenciatura Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City C.P. 03100, Mexico.
- Academia de Matemáticas, Universidad Autónoma de la Ciudad de México, Mexico City C.P. 09790, Mexico.
- Departamento de Bioquímica, CINVESTAV-IPN, Mexico City C.P. 07360, Mexico.
- Departamento de Infectómica y Patogénesis Molecular, CINVESTAV-IPN, Mexico City C.P. 07360, Mexico.
ORCID-Profile: Mario Alberto Rodríguez, Jesús Valdés, Elisa Azuara-Liceaga
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- Universidad Autónoma de la Ciudad de México
- CONAHCYT
- CCyT-UACM
Zitieren
APA
Cuellar, P., Castañeda-Ortiz, E. J., Rosales-Zarza, C., Martínez-Rodríguez, C. E., Canela-Pérez, I., Rodríguez, M. A., Valdés, J., & Azuara-Liceaga, E. (2024). Genome-Wide Classification of Myb Domain-Containing Protein Families in Entamoeba invadens. Genes. https://doi.org/10.3390/genes15020201
Vancouver
Cuellar P, Castañeda-Ortiz EJ, Rosales-Zarza C, Martínez-Rodríguez CE, Canela-Pérez I, Rodríguez MA, et al. Genome-Wide Classification of Myb Domain-Containing Protein Families in Entamoeba invadens. Genes. 2024. doi:10.3390/genes15020201
BibTeX
@article{Cuellar2024,
author = {Cuellar, Patricia and Castañeda-Ortiz, Elizabeth J and Rosales-Zarza, César and Martínez-Rodríguez, Carlos E and Canela-Pérez, Israel and Rodríguez, Mario Alberto and Valdés, Jesús and Azuara-Liceaga, Elisa},
title = {Genome-Wide Classification of Myb Domain-Containing Protein Families in Entamoeba invadens},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15020201}
}
EUVIMED